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Summary
We deleted the hypoxia-responsive transcription factor HIF-1 in endothelial cells (EC) to determine its role during neovascu-
larization. We found that loss of HIF-1 inhibits a number of important parameters of EC behavior during angiogenesis:
these include proliferation, chemotaxis, extracellular matrix penetration, and wound healing. Most strikingly, loss of HIF-1
in EC results in a profound inhibition of blood vessel growth in solid tumors. These phenomena are all linked to a decreased
level of VEGF expression and loss of autocrine response of VEGFR-2 in HIF-1 null EC. We thus show that a HIF-1-driven,
VEGF-mediated autocrine loop in EC is an essential component of solid tumor angiogenesis.
Introduction VEGFR-2 (Flk-1/KDR), and VEGFR-3 (Flt-4) (Ferrara et al., 2003).
VEGFR-2 is a major mediator of mitogenic, angiogenic, and
permeability-enhancing effects of VEGF (Gille et al., 2001; Sha-Angiogenesis, the formation of new capillaries from existing
blood vessels, is required for processes ranging from placental laby et al., 1995). The precise function of VEGFR-1 in angiogen-
esis is still under debate (Ferrara et al., 2003; Shibuya, 2001).invasion to organogenesis during embryogenesis and from
wound healing to endometrial growth in adults (Folkman and VEGFR-1 has been suggested to be a negative regulator of
VEGF action during early embryonic development (Fong et al.,Klagsbrun, 1987). It is also an essential aspect of a number of
pathologies involving new tissue growth, including the growth 1999) but has been indicated as a regulator of VEGF action in
adult animals (Gabhann and Popel, 2004; Hiratsuka et al., 2001).of solid tumors, which requires angiogenesis for expansion and
metastasis (Folkman, 1996). VEGFR-3 is primarily expressed in lymphatic endothelial cells
and is thought to be primarily a regulator of lymphatic angiogen-Angiogenesis can be stimulated by lowered physiological
oxygen, or hypoxia. Hypoxia in wound healing, during cardio- esis (Jussila and Alitalo, 2002). The expression of VEGFR-1
and VEGFR-2 are upregulated by hypoxia; VEGFR-1 is directlyvascular and cerebral ischemia, and in solid tumor formation
induces the increased expression of a number of factors key upregulated by hypoxia, via a HIF binding enhancer element
located in the VEGFR-1 promoter, while the upregulation ofto mobilizing endothelial cell chemotaxis and proliferation (Pugh
and Ratcliffe, 2003; Semenza, 2001). The hypoxia-inducible VEGFR-2 by hypoxia is mediated by posttranscriptional regula-
tion (Gerber et al., 1997; Waltenberger et al., 1996).transcription factor-1 (HIF-1) acts to control induced expression
of many, if not most, hypoxia-inducible genes, and it is clear These data indicate that endothelial cells have the potential
to tightly regulate their hypoxic responses in coordination withthat HIF-1 is essential for hypoxia-induced increases in glycoly-
sis and angiogenesis in tumor cells, as well as normal tissues changes in the oxygenation of surrounding tissues. What re-
mains undefined is the role of specific interactions between(Griffiths et al., 2002; Iyer et al., 1998; Ryan et al., 1998).
The vascular endothelial growth factor (VEGF) is an essential hypoxic response, HIF-1 activation, VEGF expression, and
VEGFR-2 response in vivo, particularly during tumorigenesis.regulator of vascularization (Ferrara and Gerber, 2001). VEGF
acts on endothelial cells as both a chemotactic and mitogenic There are clearly many potential aspects of endothelial cell
function that could require hypoxic response through the HIF-1factor, via endothelial cell-specific receptors: VEGFR-1 (Flt-1),
S I G N I F I C A N C E
Antiangiogenic therapies for the treatment of cancer have as a target the process of growth factor-induced neovascularization.
This process involves the interaction of malignant cells and nontransformed endothelium. The microenvironment of the solid tumor
is often hypoxic, and the hypoxia-induced changes in expression of angiogenic factors in cancer cells have been shown to be
critical for the process of tumorigenesis. We show here that the hypoxic response of endothelial cells is an equally important
component of tumor angiogenesis and is as well a potential novel target for cell-directed cancer therapies, due to the involvement
of a hypoxia- and HIF-1-dependent endothelial cell-specific autocrine loop.
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pathway; a recent study suggested that hypoxia-inducible gene Intracellular ATP levels are regulated by HIF-1
To determine the role of HIF-1 in regulation of EC energyexpression and migration were critically dependent on HIF-1
metabolism, we assayed ATP production by primary EC. Afterbut not HIF-2 in EC (Sowter et al., 2003). But it is still unclear
the EC were cultured for 24 hr under normoxia or hypoxia,how and to what extent this pathway regulates EC in vivo and
whole-cell extracts were prepared to compare the levels of freehow the importance of that response stands in contrast to the
ATP in the cultured cells. The amount of free ATP produced byhypoxic response from the cells and tissues in which the vascu-
each cell line was normalized for protein levels within eachlature is located. This is a pressing issue in tumor formation, in
whole-cell lysate. As shown in Figure 1D, the total amounts ofthat it is not clear how tissues interact with EC during hypoxia
free ATP produced during hypoxia were dependent on the HIF-to mobilize and accomplish neovascularization.
1 status of the EC. Interestingly, under hypoxic conditions,We have specifically removed HIF-1 from endothelial cells
free ATP increased about 1.6-fold in wild-type EC, while in nulland show here that angiogeneis in vivo is impaired by loss of
EC the level of free ATP was slightly decreased. The reductionHIF-1 in EC, demonstrating that HIF-1 is critical for EC func-
of cellular ATP in the HIF-1null EC indicates that HIF-1 activitytion during neovascularization. We demonstrate that this impair-
helps to maintain intracellular ATP at wild-type levels in endothe-ment is a direct result of the disruption of an autocrine loop,
lial cells under these hypoxic, albeit normoglycemic, conditions.acting through HIF-1 regulation of hypoxia-induced VEGF ex-
pression.
Conditional deletion of HIF-1 in vivo
by bone marrow transplantationResults
We created a conditional deletion of the HIF-1 transcription
factor in endothelial cells in vivo via crosses into a backgroundHIF-1 is required for hypoxia-inducible gene
of cre recombinase expression driven by the Tie2 promoter,transcription in murine endothelial cells
which allows specific deletion in the endothelium (Kisanuki etTo determine if HIF-1 is expressed in primary EC in a hypoxia-
al., 2001). It has been shown that the Tie2-cre transgenic mousedependent manner, EC from conditionally targeted mice were
line facilitates cre recombinase expression in endothelial cellspurified from lungs and then cultured under normoxic, hypoxic,
and in hematopoietic cells (Constien et al., 2001). Here we alsoand anoxic conditions; 72 hr prior to hypoxic culture, cells were
found high efficiency of recombination (approximately 98%) ininfected with Cre recombinase-expressing adenovirus to induce
cells from the bone marrow isolated from Tie2 cre/HIF-1 condi-
deletion of the conditional alleles of HIF-1; wild-type cells were
tionally null mice (Figure 1F, gray bar). To create endothelial
infected with a control adenovirus. Nuclear and cytosolic ex-
cell-specific HIF-1 null mice, we performed bone marrow re-
tracts were assayed for HIF-1 protein expression: as shown
constitution to rescue the deletion of the HIF-1 gene in hemato-
in Figure 1A, only nonspecific signals and not HIF-1 protein poietic cells (Figure 1E). More than 80% of the hematopoietic
can be detected in cytosolic extracts, and in EC, there was only cells of EC null mice were then recovered as wild-type (Figure
a weak induction of HIF-1 protein during hypoxic culture (0.5% 1F, white bar).
O2). Much more nuclear induction of HIF-1 was observed in
response to culture under anoxic conditions in wild-type cells Defective VEGF-induced migration and proliferation
(Figure 1A). The expression of HIF-2 protein was checked in in matrigel in vivo
nuclear and cytosolic extracts of EC. As shown in Figure 1A, During angiogenesis, EC differentiate and proliferate in situ
we found that HIF-2 protein was localized primarily to the within a previously avascular tissue and then coalesce to form
cytoplasm. HIF-2 protein expression levels in EC are not differ- a primitive tubular network. To analyze the effects of the condi-
ent regardless of the presence of HIF-1. There is no detected tional loss of HIF-1 function during angiogenesis in vivo, we
HIF-2 protein expression in nuclear extracts of EC. applied a murine matrigel plug assay to HIF-1f/f (wild-type)
It has been shown that HIF-1 is ubiquitously transcribed mice and HIF-1f/f Tie2-cre (null) mice (Kisanuki et al., 2001).
but that the primary site of mRNA expression of the highly This is a well-established in vivo angiogenesis model; the level
related transcription factor HIF-2 is the endothelium (Ema et of angiogenesis is typically viewed by embedding and sec-
al., 1997; Flamme et al., 1997; Jain et al., 1998; Tian et al., tioning the plugs in paraffin and staining using Masson’s Tri-
1997). To determine the level of redundancy of HIF-1 in EC chrome (Passaniti et al., 1992). Matrigel plugs containing recom-
and to determine if HIF-1 alone is essential for hypoxia-induced binant murine VEGF at 20 ng/ml were implanted subcutaneously
transcription in primary endothelial cells, the expression levels in the flanks of bone marrow-rescued Tie2-cre/HIF-1 condi-
of three known HIF-1 targets were assayed in these cells: the tional mice (EC null) and controls; 8 days after implantation, the
glycolytic enzyme phospoglycerate kinase PGK, the glucose matrigel plugs were removed and analyzed. The matrigel plugs
transporter GLUT1, and VEGF following purification of endothe- removed from wild-type mice (Figure 2A) were yellowish, an
lial cells from lungs of conditionally targeted animals (purification initial gross indication of significant angiogenesis. Masson’s
levels shown in Figure 1B). The mRNA expression levels were trichrome staining showed that there were considerable num-
compared in primary cultures of wild-type and HIF-1/ EC, bers of vessels in the plugs (Figure 2C). The plugs removed
cultured at normoxia or hypoxia. The hypoxia-inducible expres- from HIF-1f/f EC null mice were relatively colorless (Figure
sion of PGK, GLUT1, and total VEGF was reduced significantly 2B). At higher magnification, it was clear that the vessels in
by loss of HIF-1 (Figure 1C) in a manner similar to that seen matrigel plugs contained erythrocytes, indicating that they had
in other tissues without HIF-1 (Seagroves et al., 2001). This formed functional capillaries (black arrows in Figures 2E and
indicates that HIF-2 and/or other hypoxia-induced factors can- 2F). When viewed by Masson’s trichrome staining, there was a
not act in such a way as to make HIF-1 completely redundant 50% deduction in vessel density by Image J analysis, and in
addition, most of the vessels only migrated to the edge of thein endothelium.
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Figure 1. Microvascular endothelial cells contain functional HIF-1
A: Top: HIF-1 protein was slightly induced in the nuclear extracts of the purified wild-type EC upon exposure to 0.5% oxygen level. Under anoxic conditions,
HIF-1 was induced to a greater extent. Middle: Only nonspecific bands, but not HIF-1 protein, could be detected in the cytosolic extracts of wt and null
EC. Bottom: HIF-2 protein could be detected in the cytosolic extracts of wt and null mEC regardless of oxygenation. NE, nulear extracts; CE, cytosolic
extracts.
B: FACScan analysis of the purity of the isolated EC: about 98.6% cells were EC by a CD31 marker.
C: Purified EC were cultured under either 20% (black bars) or 0.5% (white bars) oxygen levels for 8 hr, harvested, and expression of target genes was
normalized to 18S rRNA. After normalization, the relative expression of each gene was expressed as a percentage of that observed in wild-type cells at
normoxia (mean  SD). No significant differences in gene expression were observed for any gene between HIF-1 wild-type (wt, HIF-1f/f infected with
Adeno-gal) and null cells (null, HIF-1f/f infected with Adeno-cre) cultured under 20% oxygen conditions, but under 0.5% oxygen, induction of all three
mRNAs in HIF-1 null cells was decreased by at least 50%.
D: Wild-type (wt) and HIF-1 null (null) primary EC were cultured under 20% (black bars) or 0.5% (white bars) oxygen conditions for 24 hr. Then the cells
were harvested and intracellular ATP concentrations were measured by means of a luciferase-based chemiluminescent assay. Statistical analysis was
performed using the unpaired Student’s test, **p  0.01.
E: The scheme of donor and recipient groups in the bone marrow transplantation experiment. BM, bone marrow.
F: Efficiency of HIF-1 deletion in EC and bone marrow cells (BM cells). Genomic DNA was prepared from EC (black bar), BM cells (gray bar) of HIF-1f/f/
Tie2-cre mice before the bone marrow transplantation, BM cells (white bar) of HIF-1f/f/Tie2-cre mice after transplanted with HIF-1f/f bone marrow,
and BM cells (dotted bar) of HIF-1f/f mice after transplanted with HIF-1f/f/Tie2-cre bone marrow.
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2000). During wound healing, endothelial sprouts are induced by
angiogenic factors; these sprouts then migrate into avascular
zones to reestablish connection with the circulation (Tonnesen
et al., 2000). EC response to hypoxia is thus likely one of the
key responses in the process of wound healing. To determine
the amount of hypoxia in early stages of cutaneous wound
healing, the hypoxic areas of the wounds were visualized in
pimonidazole-treated mice using the hypoxyprobe-1 mono-
clonal antibody. As can be seen in Figure 3A, there is a significant
degree of hypoxia at the wound margin in experimental wounds
(brown staining at wound margin).
To determine rates of wound closure, we performed three
6 mm circular punch biopsies on the back skin of each of ten
HIF-1 wild-type and HIF-1 EC null littermates after recovery
from bone marrow transplantation, and we measured wound
closure daily over a 12-day period. As shown in Figure 3B,
wound healing was significantly delayed in the HIF-1f/f/Tie2-
cre EC null mice compared with wild-type littermates (*p 0.05,
**p  0.01 at day 3, 4, 5, 6). Histological changes in early stage
wounds were examined by H&E staining. At day 6 postinjury,
the epidermis of wild-type wounds deeply migrated under the
fibrin clot (Figure 3C), while the leading epidermal edge of EC null
wounds did not clearly invade into the fibrin clot and remained at
the wound margin at this stage of healing (Figure 3D).
At very early stages of wound healing, new capillary sprouts
develop from dilated vessels adjacent to the wounds and invade
to the wound clot (McClain et al., 1996; Singer and Clark, 1999).
To determine the amount of capillary formation in wound heal-
ing, we detected endothelial sprouting by immunostaining. At
day 3 postinjury, new capillary sprouts of wild-type wounds
emanated from the dilated vessels adjacent to the wounds (Fig-
ure 3E). In the wounds of HIF-1f/f/Tie2-cre EC null mice, there
were fewer new capillaries emanating from tissues adjacent to
the wounds (Figures 3F and 3G, graph). These assays demon-
strate that loss of HIF-1 in endothelial cells results in abnormal
angiogenesis of wounds, which leads in turn to a delay in
healing.
Figure 2. VEGF-induced angiogenesis in murine matrigel model is defective
in HIF-1f/f/Tie2-cre EC null mice Reduced tumor size and severely necrotic tumors
A and B: VEGF-permeated matrigel plugs from wild-type (wt) (A) are grossly in HIF-1 EC null mice
more obviously vascularized than those from HIF-1 EC null (B) mice. Scale Tumors typically initiate as small avascular masses and can
bar equals 500 m.
develop a severely hypoxic microenvironment; this subse-C and D: Masson trichrome-stained sections of matrigel plugs. Scale bar
quently can act to help induce the angiogenesis that is requiredequals 100 m.
E and F: Sections from wt (E) and HIF-1 EC null (F) mice were individually to allow further tumor growth (Folkman, 1971, 1996; Hanahan
imaged at higher power to highlight the vessel structure in the matrigel and Folkman, 1996; Thomlinson and Gray, 1955). The regulation
plugs. The black arrows indicate that these vessels contain erythrocytes. of angiogenesis by hypoxia is an important link between vascu-
Scale bar equals 25 m.
lar oxygen supply and tumor metabolic demand. We performedG: Mean vessel density in matrigel plugs from wt (white bar) mice and HIF-1
a standard assay of tumorigenesis to determine whether theEC null (black bar) mice was determined with Image J software. Error bars
indicate standard deviation (SD). Statistical analysis was performed using defects in null EC would affect tumor growth. Lewis lung carci-
the unpaired Student’s test, **p  0.01. noma cells will grow in immunocompetent C57Bl6 mice (O’Reilly
et al., 1997), and so were injected subcutaneously into the HIF-
1 wild-type and HIF-1f/f/Tie2-cre EC null mice after bone
marrow transplantation. It has been suggested that endothelialmatrigel plugs (Figures 2D and 2G). These results demonstrate
progenitor cells and bone marrow-derived myeloid cells can bethat loss of HIF-1 in endothelial cells disrupts VEGF-dependent
involved in tumor angiogenesis (Rabbany et al., 2003; Rafii etsignaling pathways in vivo.
al., 2002). Therefore, we performed the tumor experiment with
the third group (BM null) of mice, in which HIF-1f/f mice wereHIF-1 EC null mice exhibit delayed wound healing
transplanted with HIF-1f/f/Tie2-cre bone marrow cells (FigureNew microvascular network formation is a critical component of
1E). As shown in Figure 1F, about 90% of HIF-1 was deletedwound healing (Ferrara, 2002; Tonnesen et al., 2000). Numerous
in bone marrow in BM null mice 8 weeks after bone marrownew capillaries carry oxygen and nutrients to sustain the metab-
olism that is needed during the healing process (Tonnesen et al., reconstitution. A control group of nonirriadiated, non-bone mar-
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row-transplanted HIF-1f/f/Tie2-cre mice also performed the
tumor experiment in parallel.
Tumors from HIF-1 EC null mice only reached 60% the
weight of tumors from wild-type mice at 15 days postinjection.
Tumors from BM null mice are slightly smaller than tumors from
wild-type mice, but the difference is not statistically significant.
Tumors from HIF-1f/f/Tie2-cre mice without bone marrow
reconstitution (average tumor weight is 0.44 g) are slightly
smaller than the tumors from HIF-1 EC null mice (average
tumor weight is 0.55 g). There is a significant difference in tumor
weight between BM null mouse group and non-bone marrow-
transplanted HIF-1f/f/Tie2-cre mouse group (Figure 4A). The
results clearly suggest that the defects observed in tumor
growth are primarily due to loss of HIF-1 in EC, despite the
possibility that loss of HIF-1 in bone marrow might also play
a role during tumorigenesis.
In addition, the tumors removed from EC null mice showed
severe central necrosis (Figure 4C), while much smaller necrotic
areas were seen in the tumors removed from wild-type mice
(Figure 4B). The tumors removed from non-bone marrow-trans-
planted HIF-1f/f/Tie2-cre mice also showed the same severe
central necrosis phenotype as tumors from EC null mice (N.T.
and R.S.J., unpublished observation).
We next analyzed microvessel density (MVD) in these tu-
mors. Vessels were visualized by immunostaining with anti-
CD31 antibodies, and the density of the vessels was calculated
by Image J software. There was a 50% reduction in tumor vessel
density in the tumors removed from HIF-1f/f/Tie2-cre EC null
mice (Figures 4D–4F). Characterization of tumor endothelial cell
proliferation in vivo was done: in Figures 4H and 4I, it can be
seen that loss of HIF-1 in the endothelial cells (stained brown)
results in fewer endothelial nuclei that stain positively for incor-
porated BrdU (blue nuclei, Figures 4H and 4I, and graph, 4G).
These results demonstrate that loss of HIF-1 in endothelial
cells impairs tumor angiogenesis, with a resulting severe central
necrosis in the solid tumor mass, and point to a central role for
Figure 3. Wound healing is delayed in HIF-1 EC null mice
endothelial cell hypoxic response during tumor angiogenesis.
A: Hypoxyprobe-1 immunostaining was performed to the paraffin sections
of wounds at day 6. Scale bar equals 50m. The hypoxic areas (brown color)
HIF-1 regulates proliferation of endothelialwere visualized in pimonidazole-treated mice. Counterstain is hematoxylin.
B: The measurement of the wound healing in wt (closed square) and EC cells during hypoxia
null (closed triangle) mice. 8 weeks after the mice were transplanted with The hypoxia-induced mitogenic response is one of the key steps
wild-type bone marrow, wound-healing experiments were performed. The in endothelium-driven neoangiogenesis during hypoxic stress
percentage of the original wound area was calculated and the results
(Michiels et al., 2000; Pugh and Ratcliffe, 2003). Previous datawere shown as mean value (SEM). The wound healing of HIF-1 EC null
from our laboratory demonstrated that transformed cell growthanimals was significantly delayed from the third day to the sixth day. Statisti-
cal analysis was performed using the unpaired Student’s test, *p  0.05, was deficient in cells lacking HIF-1, particularly under hypoxic
**p  0.01. conditions (Seagroves et al., 2001). To determine the extent to
C and D: Hematoxylin and eosin-stained paraffin sections of wounds at day
which HIF-1 was required during hypoxic growth of EC, we6. Scale bar equals 50 m. Note the epidermal leading edge was migrating
evaluated growth rates following loss of HIF-1 in immortalizedunder the wound clot in the wt animals (C), versus the epidermal leading
edge at the edge of the wound in the HIF-1 EC null animals (D). EC lines.
E and F: CD31 immunostaining (brown color) was performed on frozen We isolated EC lines from animals with a conditional muta-
sections of wounds at day 3. Scale bar equals 50 m. Counterstain is hema- tion in HIF-1. These animals were also homozygous for a dele-
toxylin. Note the neovascularization of the wounds in wt animals (E) relative
tion of the p53 gene, allowing rapid outgrowth and EC lineto preexisting dilated vessels (black arrows); new vessels have migrated
establishment. These EC lines were used in this study becausetoward the edge of the wound (red arrow indicates the direction of vessel
migration). In HIF-1 EC null animals (F), there is no migration path near the primary EC do not proliferate well at passage 2. Following estab-
wound margin. lishment, cells were treated with adenovirus expressing Cre
G: Mean vessel density in wounds from wild-type (white bar) and EC null
recombinase, in order to delete the HIF-1 gene.(black bar) mice in wound margin fields was determined with a chalkley
As seen in Figure 5A, the EC cell line lacking HIF-1 (labeledeyepiece graticule.
Statistical analysis was performed using the unpaired Student’s test, **p  null) was able to grow at approximately the same rate as a wild-
0.01. type control EC line (wt) under normoxic conditions. As seen in
Figure 5B, wild-type EC have the same growth rate under hyp-
oxia and normoxia. However, HIF-1 null cells grew more slowly
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Figure 4. Reduced tumor size in HIF-1 EC null mice
A: Wild-type (wt) mice (closed square), EC null mice (closed triangle), BM null mice (closed circle), and non-bone marrow-transplanted HIF-1f/f/Tie2-cre
mice (closed diamond) were inoculated subcutaneously with 8  106 Lewis lung carcinoma cells, and tumors were dissected after 15 days and weighed
(lines indicate mean tumor weight). Statistical analysis was performed using the unpaired Student’s test, *p  0.05, **p  0.01.
B and C: Hematoxylin & eosin (H&E) staining of tumors from wt mice (B) and HIF-1 EC null mice (C) (scale bar equals 500 m). Note necrotic areas (N) in
the tumors from HIF-1  EC null mice.
D: Mean vessel density in tumors from wt (white bar) and HIF-1 EC null (black bar) mice was determined with Image J software. Error bars indicate standard
deviation (SD).
E and F: The CD31 staining (blue color) of frozen sections of tumors from wt (E) and HIF-1 EC null mice (F) (scale bar equals 500 m). Counterstain is nuclear
fast red.
G: Proliferating endothelial cells in tumors from wt mice (white bar) and HIF-1 EC null mice (black bar) were determined by labeling and counting cells
with both BrdU- and CD31-positive staining per 200 field. Error bars indicate standard deviation (SD).
H and I: The BrdU (blue nuclei) and CD31 (brown) double staining of sections of tumors from wt (H) and HIF-1 EC null (I) mice. Scale bar equals 50 m.
Black arrows indicate cells stained with both colors. Counterstain is nuclear fast red.
Statistical analysis was performed using the unpaired Student’s test.
in the exponential phase of culture under hypoxia. As seen in and assayed EC from VEGF conditionally deleted animals (Ger-
ber et al., 1999), in a manner similar to that described for isolationFigure 5C, the growth of both wild-type and null EC was arrested
after 48 hr culture under anoxic conditions, although the wild- and characterization of HIF-1 null EC.
To determine whether HIF-1 is involved in this process, andtype cells still had a significant survival advantage under these
conditions. the extent to which it might be dependent on VEGF expression
induced by hypoxia, we tested the capacity of primary wild-
type, HIF-1 null, or VEGF null primary EC to organize into tubesHIF-1 null EC and VEGF null EC have defects
in capillary structure formation in vitro. Under normoxia, both wild-type and, to a lesser extent,
HIF-1 and VEGF null EC (Figure 6A) elongated on matrigelon matrigel substratum under hypoxia
A major attribute of new blood vessel formation is capillary substrata within 6 hr of plating. At hypoxia, tube formation was
induced, and tubular networks formed in the wild-type EC (Fig-sprouting and tube formation by migrating EC, which may be
stimulated by hypoxia (Kroon et al., 2001; Phillips et al., 1995), a ures 6A and 6B) at an increased rate relative to normoxia, dem-
onstrating the role of hypoxic induction in capillary formation inprocess thought to be regulated in part by paracrine or autocrine
VEGF. A requirement for HIF-1 in motility might be due to a primary EC. In contrast, tubular structures were greatly reduced
in the HIF-1 null EC and were inhibited to a slightly greaterdefect in autocrine or paracrine production of VEGF, in a HIF-
1-dependent manner. To determine the extent to which loss extent in VEGF null EC.
Due to the similarity of the tube formation phenotype underof VEGF production affects motility toward VEGF, we isolated
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mouse VEGF 164 (rmVEGF164) as a chemotactic factor to ana-
lyze the directional migration of wild-type, HIF-1null, and VEGF
null primary EC through a matrigel-coated Boyden chamber
under hypoxic conditions. We assayed random motility through
assays where serum was at high levels in both the upper and
lower chambers (Figure 7B) and directed motility/chemotaxis,
where VEGF was placed only in the lower chamber under low
serum conditions (Figure 7A).
The motility of both VEGF null and HIF-1 null EC is greatly
reduced under hypoxia in the directed assay (Figure 7A). How-
ever, in an assay of random motility (Figure 7B), the HIF-1 null
EC are essentially as motile as wild-type cells, whereas the
VEGF null EC have a greatly reduced level of migration, presum-
ably due to defects in autocrine VEGF-induced cell movement.
Hypoxia-induced expression of VEGF receptors
in EC requires HIF-1
Hypoxia has been proposed to play an important role in the
upregulation of VEGF receptor gene expression. It has been
shown that VEGFR-1 is transcriptionally upregulated by HIF-1
under hypoxic conditions (Gerber et al., 1997), while VEGFR-2
receptor expression is mediated by posttranscriptional mecha-
nisms such as enhanced protein stability (Waltenberger et al.,
1996). To investigate the expression of VEGFR-1 and VEGFR-2
in primary wild-type and mutant EC, they were cultured under
normoxia, hypoxia, and anoxia for 24 hr, and total RNA and
protein were isolated. The mRNA expression of VEGFR-1 and
VEGFR-2 were determined by real-time PCR following normal-
ization to 18S rRNA. We found a 2.5-fold increase of VEGFR-1
mRNA in wild-type EC under hypoxia, and this hypoxic induction
of VEGFR-1 mRNA was partially blocked by the loss of HIF-1;
levels in VEGF null EC were similar to those seen in wild-type
cells (Figure 7C). This was correlated with the protein expression
levels of VEGFR-1, which were upregulated under hypoxia and
anoxia in wild-type and VEGF null EC, but not in HIF-1 null
Figure 5. Growth of HIF-1 null EC is reduced during hypoxia EC (data not shown). VEGFR-2 mRNA levels were decreased
slightly in HIF-1 and VEGF null EC under normoxic conditions.Following overnight seeding at a low density, HIF-1 null EC were incubated
under 20% (A), 0.5% (B), or 0% (C) oxygen conditions in DMEM high-glucose In wild-type EC, the protein expression levels of VEGFR-2
with 10% FCS medium and harvested every 24 hr until the cultures reached were increased about 2.5-fold by hypoxia, while in both HIF-1
confluence. The average cell number of triplicate plates for each condition
null and VEGF null EC, VEGFR-2 levels were not changed by(mean  SEM) was determined by counting by hemacytometer following
culture in hypoxia (Figure 7D). These results demonstrate thattrypsinization. The maximal difference in growth rates between wt (closed
triangle) and null (open square) EC was noted at 72 hr posthypoxia. loss of HIF-1 induction/regulation of EC-produced VEGF dis-
Statistical analysis was performed using the unpaired Student’s test, *p  rupts an autocrine loop, interrupting increased expression of
0.05, **p  0.01. VEGFR-2 caused by increased VEGF expression.
Discussion
hypoxia in HIF-1 null EC and VEGF null EC, we determined
There is a great deal of experimental evidence that the growththe rate at which hypoxia induces VEGF secretion in HIF-1
of transformed cells in vivo requires a hypoxic response andnull EC. Analysis of VEGF protein levels in the EC-conditioned
that this occurs primarily through the action of HIF-1 (Semenza,medium of cells cultured under normoxia, hypoxia, and anoxia
2003). Recent data has also demonstrated that there is a site-for 24 hr (Figure 6C) shows that the levels of VEGF protein are
specific aspect for the requirement for HIF-1 in malignant cells,approximately similar in wild-type and HIF-1 null EC under
where the vascular network available at the site of tumor growthnormoxic conditions but are greatly reduced under hypoxia or
is a critical determinant of the overall rate and invasiveness ofanoxia.
tumorigenic progression (Blouw et al., 2003). The data pre-
sented here argue that targeting of HIF-1 response in theAutocrine VEGF in EC regulates motility, but hypoxia-
endothelium also has to be taken into account.mediated VEGF production regulates directed chemotaxis
Endothelial cells are able to withstand large fluxes in oxygenMigration of endothelial cells toward tissues or solid tumors
and maintain physiological integrity; this presumably allowsthat are secreting VEGF or other angiogenic factors is a critical
them to migrate into hypoxic and even anoxic sites duringaspect of angiogenesis (Ferrara, 2002). To determine the func-
tional role of HIF-1 in EC migration, we used recombinant wound healing to reestablish oxygenation (Ten and Pinsky,
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Figure 6. HIF-1 regulation of endothelial cell au-
tocrine VEGF is essential for capillary-like tube
formation in vitro
A: EC tube formation assay: 5  104 primary EC
in 0.5 ml medium containing 0.5% FCS were
plated on growth factor-reduced matrigel sub-
stratum. Then the cells were left at 20% oxygen
(top) or were transferred to 0.5% oxygen condi-
tions (bottom) for 8 hr. The network formation
was viewed by phase-contrast microscopy at
40 magnification. At 20% oxygen conditions,
after 8 hr plating, both wild-type (left top) and
HIF-1 null (middle top) EC began to form capil-
lary-like structures. Fewer capillary-like tubes
were observed in VEGF null EC (right top). At 0.5%
oxygen conditions, tube formation was induced
in wild-type EC (left bottom). Few tubes were
induced in the HIF-1 null EC (middle bottom)
and VEGF null EC (right bottom) incubated un-
der 0.5% oxygenation. Scale bar equals 200 m.
B: The length of tube-like structures was mea-
sured by analyzing digitized images (4 random
images per well) (40) by Image J software. *p
0.05, **p  0.01.
C: Expression of VEGF protein in wild-type (wt)
and HIF-1 null EC. Confluent monolayer cells of
both cell types were cultured under 20% (black
bars), 0.5% (gray bars), or 0% (white bars) oxygen
conditions for 24 hr, conditioned supernatant
was harvested, and VEGF protein levels ana-
lyzed by ELISA.
2002; Tretyakov and Farber, 1995). As part of the response relative to other HIF-1 null cell types, arguing against a specific
role for HIF-2 in endothelial cell hypoxic response. This is into hypoxia, all cells require a robust capacity for anaerobic
generation of energy, and endothelial cells are particularly de- agreement with a previous study (Sowter et al., 2003). It remains
to be determined how HIF-2 regulates endothelial cell re-pendent on the glycolytic pathway (Culic et al., 1997). We de-
scribe here that loss of HIF-1 has a deleterious effect on hyp- sponse to hypoxia, or what its exact role is, given the evidence
for its EC-specific expression.oxic ATP levels in primary endothelium. This likely gives rise to
alterations in the overall capacity of the endothelium to prolifer- Cutaneous wound healing requires a coordinated migration
of endothelial cells into the wound margin, and a subsequentate and invade into tissues where oxygen levels are limited,
although our data indicate that random motility of the cells is reorganization of the EC, with a concomitant formation of new
capillaries to reestablish circulation under the reformed epithelialnot affected during hypoxia.
A possible mechanism to compensate for the absence of layer (Ferrara, 2002; Li et al., 2003b; Tonnesen et al., 2000). We
have shown that HIF-1-mediated endothelial cell function isHIF-1 is the redundancy of the HIF-1 pathway. A close homo-
log of HIF-1, HIF-2, has been connected in the literature important for early events in this process, but that the absence
of HIF-1 can be compensated for in later stages of woundextensively to endothelial cells, and in fact was labeled endothe-
lial PAS protein-1 (EPAS1) by one of the groups that first cloned healing. However, some wounds in HIF-1EC null animals re-
main unhealed for long periods; and the resolution of thesethis transcription factor (Ema et al., 1997; Flamme et al., 1997;
Jain et al., 1998; Tian et al., 1997). It has been shown that wounds is also typically less successful than is the case in wild-
type animals (N.T. and R.S.J., unpublished observation). ThisHIF-1 shares some common targets with HIF-2, but HIF-1
also has unique targets different from HIF-2 (Hu et al., 2003). argues that endothelial cell migration stimulated by hypoxia is
required for successful resolution of wound healing, and notHIF-2 is highly expressed in endothelial cells in vivo but can
be found in a wide range of other cell types as well. Its function, just for the initial process of reepithelialization.
Loss of HIF-1 in all tissues results in an early embryonichowever, is generally unclear, although one recent paper has
shown that HIF-2 has a role in regulating the response to lethality, with significant deficits in embryonic and yolk sac vas-
cularization (Iyer et al., 1998; Ryan et al., 1998). Capillaries inoxidative stress (Scortegagna et al., 2003). We have shown
previously that in cells lacking HIF-1, HIF-2 is unable to com- the global HIF-1 knockout embryos are largely absent and are
disorganized in the embryonic yolk sac of the HIF-1 null mu-pensate during hypoxic stress; this appears to be due to a
cytoplasmic segregation of the HIF-2 protein, which is refrac- tants (Iyer et al., 1998; Ryan et al., 1998). The Tie2 transgene
is expressed in hemagioblasts at early E7.5 stage of develop-tory to hypoxia (Park et al., 2003). We see no compensation in
hypoxic response in HIF-1 null endothelial cells in this study, ment and is able to induce recombination of the conditional
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Figure 7. Loss of HIF-1 impairs EC movement to-
ward rmVEGF164
A: Migration of EC to VEGF was analyzed in Boy-
den chambers. Wild-type (white bars), HIF-1 null
(gray bars), and VEGF null (black bars) EC in
transwells with medium containing 0.5% FCS
were allowed to migrate toward 20 ng/ml
rmVEGF164 in lower wells with medium con-
taining 0.5% FCS for 24 hr under 0.5% oxygen
conditions. The migrating cells were stained as
described in Experimental Procedures.
B: Random motility of EC was analyzed in Boyden
chambers with medium containing higher levels
of serum (5% FCS) in both upper and lower wells.
Wild-type (white bars), HIF-1 null (gray bars),
and VEGF null (black bars) EC in transwells were
allowed to migrate randomly for 24 hr under 0.5%
oxygen culture conditions.
C: Primary wild-type (wt) EC, HIF-1 null EC, and
VEGF null EC were cultured under 20% (black
bars) or 0.5% (white bars) oxygen conditions for
24 hr. The mRNA expression levels of VEGFR-1 and
VEGFR-2 were examined by real-time PCR, with
gene expression normalized to 18S rRNA.
D: Expression of VEGFR-2 protein in wild-type, HIF-
1 null, and VEGF null EC was influenced by oxy-
gen level. Primary wild-type and HIF-1 null EC
were cultured under 20%, 0.5%, or 0% oxygen
levels for 24 hr (top). Primary wild-type and VEGF
null EC were cultured at 20% or 0.5% oxygen con-
ditions for 24 hr (bottom). Western blot analysis
was detected using anti-mouse VEGFR-2 antibody and a chemiluminescence-based detection system for visualization. Equal protein loading controls were
shown by -actin blots. Western results were analyzed by a Typhoon scanner and ImageQuant software and shown in the bar graph.
Similar results were obtained in at least three independent experiments.
gene in vivo at least at E8.5 (Cattelino et al., 2003; Kisanuki et of this model in conjunction with tumor cells that lack HIF-1, or
lack one of its targets, such as VEGF, will help to model targetedal., 2001). The normal development of the HIF-1 EC null mice
indicates that the defects in capillarization seen in early mutant treatments much better than currently experimentally possible.
In such experiments, it will be possible to assess effects onembryos may be due to changes in the hypoxic response of
the underlying tissues, and not in the EC. It is an interesting both transformed cells and critical stromal compartments. In
this way, genetic models can be created that more truly mimicaspect of this mutation that there is a profound effect on wound
healing and tumorigenesis, but no discernible effect on normal the pharmacology of inhibited hypoxic response.
In summary, we have shown that loss of HIF-1 or VEGFvascularization during development. Further work will be needed
to determine if there are more subtle effects on developmental in EC interrupts an autocrine loop necessary for the posttran-
scriptional hypoxic induction of VEGFR-2 expression. This dem-vascularization caused by deletion of EC HIF-1. We also cannot
totally exclude the possibility of a functional redundancy of HIF- onstrates that loss of HIF-1 affects function of EC during their
directed migration toward regions of hypoxia and, thus, higher1 and HIF-2 during embryonic development. The study of
the development of HIF-2 EC null mice will be helpful to eluci- levels of VEGF. This feedback mechanism of hypoxic response
in EC is necessary for the proper neovascularization of woundsdate this question.
Perhaps most strikingly, we have found that the loss of the and the growth of one type of experimental solid tumor and
hypoxia-responsive transcription factor HIF-1 severely alters indicates that HIF-1-directed hypoxic response can be critical
the morphology, vascularization, necrosis, and growth of tu- in indirect as well as direct control of cellular responses in vivo.
mors. These data demonstrate that loss or inhibition of hypoxic
Experimental proceduresresponse as a component of cancer therapy may need to target
endothelium in the first instance, where it may indeed be more
Animals
efficacious then the targeting of that response in malignant cells All animal experiments were conducted in accordance with the NIH Guide
themselves. In addition, the overall normal viability and lack of for the Care and Use of Laboratory Animals. Endothelial cell-specific inactiva-
overt phenotype in uninjured mice with HIF-1 null endothelium tion of HIF-1 was achieved by cross-breeding Tie2-Cre transgenic mice
(Kisanuki et al., 2001) with HIF-1f/f mice homozygous for the HIF-1 alleledemonstrates that inhibition of the transcription factor should
with exon2 flanked by loxp sites (Ryan et al., 1998). In all experiments,not adversely affect the overall health of treated patients, if the
littermates from the same breeding pair were used as controls.treatment itself is targeted to EC.
Further experiments on tumor growth in different sites in this
In vitro endothelial cell culture
model are critical; they will help determine how tumorigenesis is Mouse lung endothelial cells were isolated from HIF-1f/f mice, VEGFf/f
affected by endothelial response when the endothelial network mice, or p53/ HIF-1f/f mice and cultured as previously described (Dong
et al., 1997).itself is handicapped in its hypoxic response. In addition, the use
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